Ibogaine & Addiction
What I Learned Going Through Ibogaine Treatment for Addiction
In 2017, I went through an Ibogaine treatment in a clinical setting.
I was not expecting it to change my direction in life. This is what
actually happened — and why the peer-reviewed research showing 60–80%
opioid abstinence rates does not surprise me at all.
Digital Health
Why I'm Building Technology for Psychedelic-Assisted Therapy
The science of psychedelic-assisted therapy is advancing faster than
the systems built to deliver it. AI, digital therapeutics, and connected
health platforms are the infrastructure layer this field is missing.
That is the problem Quelm is built to solve.
Access & Policy
The Addiction Treatment Access Problem and Why Technology Can Fix It
80% of people with addiction never receive treatment. The barriers
are systemic: cost, stigma, geography, and a lack of trusted information.
My mother was one of those 80%. Every product I build is aimed at
moving that number.